These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7651398)

  • 21. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
    Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
    Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
    Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain.
    Ishiguro Y; Iwashita T; Murakami H; Asai N; Iida K; Goto H; Hayakawa T; Takahashi M
    Endocrinology; 1999 Sep; 140(9):3992-8. PubMed ID: 10465268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
    Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
    Yajnik V; Blaikie P; Bork P; Margolis B
    J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.
    Okada S; Kao AW; Ceresa BP; Blaikie P; Margolis B; Pessin JE
    J Biol Chem; 1997 Oct; 272(44):28042-9. PubMed ID: 9346957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
    Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
    Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells.
    Barnes H; Larsen B; Tyers M; van Der Geer P
    J Biol Chem; 2001 Jun; 276(22):19119-25. PubMed ID: 11259429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of Shc to the NPXY motif is mediated by its N-terminal domain.
    Prigent SA; Pillay TS; Ravichandran KS; Gullick WJ
    J Biol Chem; 1995 Sep; 270(38):22097-100. PubMed ID: 7673183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
    Lioubin MN; Algate PA; Tsai S; Carlberg K; Aebersold A; Rohrschneider LR
    Genes Dev; 1996 May; 10(9):1084-95. PubMed ID: 8654924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
    Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
    Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
    Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
    J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
    Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
    Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
    Ueno H; Hirano N; Kozutsumi H; Sasaki K; Tanaka T; Yazaki Y; Hirai H
    J Biol Chem; 1995 Aug; 270(34):20135-42. PubMed ID: 7650032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
    Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
    Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
    Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.